Copyright
©2008 The WJG Press and Baishideng.
World J Gastroenterol. Apr 7, 2008; 14(13): 2049-2054
Published online Apr 7, 2008. doi: 10.3748/wjg.14.2049
Published online Apr 7, 2008. doi: 10.3748/wjg.14.2049
Table 1 Characteristics of the subjects in this study
| Subject | CYP2C19 | Age | Height (cm) | Body weight (kg) | BMI |
| 1 | Hetero | 33 | 175 | 70 | 22.8 |
| 2 | Hetero | 50 | 175 | 73 | 23.8 |
| 3 | Hetero | 31 | 168 | 65 | 23.0 |
| 4 | Hetero | 22 | 165 | 60 | 22.0 |
| 5 | Homo | 31 | 168 | 65 | 23.0 |
| 6 | Homo | 26 | 173 | 68 | 22.7 |
| 7 | Homo | 23 | 171 | 70 | 23.9 |
| 8 | Homo | 25 | 184 | 75 | 22.1 |
- Citation: Yamagishi H, Koike T, Ohara S, Horii T, Kikuchi R, Kobayashi S, Abe Y, Iijima K, Imatani A, Suzuki K, Hishinuma T, Goto J, Shimosegawa T. Early effects of Lansoprazole orally disintegrating tablets on intragastric pH in CYP2C19 extensive metabolizers. World J Gastroenterol 2008; 14(13): 2049-2054
- URL: https://www.wjgnet.com/1007-9327/full/v14/i13/2049.htm
- DOI: https://dx.doi.org/10.3748/wjg.14.2049